Gaithersburg biotech Emergent BioSolutions Inc. (NYSE: EBS) has tapped pharmaceutical industry veteran Joseph Papa as its new president and CEO. The appointment, effective Wednesday, comes about eight months after Bob Kramer, the company’s leader of four years and a longtime executive with the Gaithersburg firm, stepped down. Haywood Miller, an adviser to Emergent, stepped into the top slot on an interim basis and has occupied the position since then.
Biotech with Baltimore facility taps new CEO
February 22, 2024
